English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52633702    Online Users :  1020
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsu chiun"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 91-140 of 149  (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
國立臺灣大學 2009 Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy 林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII
國立臺灣大學 2009 Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy 許駿; 魏淑鉁; 鄭安理; 陳培哲; HSU, CHIUN; WEI, SHU-CHEN; CHENG, ANN-LII; CHEN, PEI-JER
國立臺灣大學 2009 Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway 陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII
國立臺灣大學 2009 Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway 陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII
國立臺灣大學 2009 Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer 葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII
國立臺灣大學 2008-06 Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新
國立臺灣大學 2008 Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer Chang, Yu-Ting; Chang, Ming-Chu; Wei, Shu-Chen; Tien, Yu-Wen; Hsu, Chiun; Liang, Po-Chin; Tsao, Po-Nien; Jan, I-Shiow; Wong, Jau-Min
國立臺灣大學 2008 Expression of Mitosis Regulatory Proteins in Biliary Tract Carcinoma: Correlation with Clinico-Pathological Features and Patient Outcome 沈盈君; 胡賦強; 鄭永銘; 張玉憲; 林宗哲; 張明志; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG -MING; CHANG, YU-SHIAHN; LIN, ZONG-ZHE; CHANG, MING-CHIH; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2008 Comparison of Hypoplastic Myelodysplastic Syndrome (Mds) with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies 黃泰中; 柯博升; 唐季祿; 許駿; 陳建源; 蔡偉; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; 田蕙芬; HUANG, TAI-CHUNG; KO, BO-SHENG; TANG, JIH-LUH; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING- CHING; WANG, CHIU-HWA; TIEN, HWEI-FANG
國立臺灣大學 2008 A Revisit of Prophylactic Lamivudine for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma: A Randomized Trial 許駿; 熊昭; 蘇益仁; 黃偉修; 張明志; 李啟誠; 巫宏博; 田蕙芬; 趙祖怡; 鄭安理; 陳培哲; HSU, CHIUN; HSIUNG, CHAO A.; SU, IH-JEN; HWANG, WEI-SHOU; CHANG, MING-CHIH; LI, CHI-CHENG; WU, HUNG-BO; TIEN, HWEI-FANG; CHAO, TSU-YI; CHENG, ANN -LII; CHEN, PEI-JER
國立臺灣大學 2008 Expression of the Nuclear Factor Kappa B (Nfkb) P50/P65 Proteins in Hepatocellular Carcinoma (Hcc): Lack of Predictive Value for Response to Thalidomide Treatment 許駿; 陳立宗; 趙毅; 沈盈君; 鄭安理; HSU, CHIUN; CHEN, LI-TZONG; CHAO, YEE; SHEN, YING-CHUN; CHENG, ANN-LII
國立臺灣大學 2008 Forkhead Box Transcription Factor Foxo3a Suppresses Estrogen-Dependent Breast Cancer Cell Proliferation and Tumorigenesis 鄭建睿; 許駿; CHENG, CHIEN-JUI; HSU, CHIUN
國立臺灣大學 2008 Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial 許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN
國立臺灣大學 2008 Geographic Difference in Clinical Trial Practice for Advanced Hepatocellular Carcinoma (Hcc): Implications on Trial Design of Global Scale 許駿; 沈盈君; 胡賦强; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HU, FU-CHANG; CHENG, ANN-LII
國立臺灣大學 2008 Imaging Adjustment with Dosimetric Verification of Cone-Beam Ct in Head and Neck Cancer Patient 許駿; 吳簡坤; 趙曉玲; 王駿瑋; 蔡巧琳; 成佳憲; HSU, CHIUN; WU, JIAN-KUEN; CHAO, HSIAO-LING; WANG, CHUN-WEI; TSAI, CHIAO-LING; CHENG, JASON CHIA-HSIEN
國立臺灣大學 2008 Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc) 沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII
國立臺灣大學 2008 Predictors of Toxicity of Weekly Docetaxel in Chemotherapy-Treated Non- Small Cell Lung Cancers 陳若白; 羅英; 余忠仁; 許駿; 施金元; 楊志新; CHEN, JO-PAI; LO, YIN; YU, CHONG-JEN; HSU, CHIUN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, CHIH- HSIN
國立臺灣大學 2008 Reconstructed Volume Loss on Cone-Beam Ct Images of Moving Targets 趙曉玲; 許駿; 吳簡坤; 成佳憲; CHAO, HSIAO-LING; HSU, CHIUN; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN
國立臺灣大學 2008 Weekly Cisplatin, Infusional High-Dose 5-Fluorouracil and Leucovorin for Advanced, Recurrent and Metastatic Cervical Carcinoma 蕭聖謀; 陳祈安; 許駿; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; HSU, CHIUN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG
國立臺灣大學 2008 Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2 陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII
國立臺灣大學 2007 Comparison of Hypoplastic Myelodysplastic Syndrome with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies 田蕙芬; 柯博升; 許駿; 陳建源; 蔡偉; 唐季祿; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; TIEN, HWEI-FANG; KO, PO-SHENG; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; TANG, JIH- LUH; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING-CHING; WANG, CHIU-HWA
國立臺灣大學 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang, Yu-Ting; Hsu, Chiun; Jeng, Yung-Ming; Chang, Ming-Chu; Wei, Shu-Chen; Wong, Jau-Min
國立臺灣大學 2007 Dynamic Mri Signals in the Second Week of Radiotherapy Relate to Treatment Outcomes of Hepatocellular Carcinoma: A Preliminary Result 梁博欽; 常慧如; 許駿; 曾鑠鑠; 施庭芳; 劉滄梧; LIANG, PO-CHIN; CHANG, HUI-JU; HSU, CHIUN; TSENG, SHUO-SHUO; SHIH, TIFFANY TING-FANG; LIU, TSANG-WU
國立臺灣大學 2007 Arsenic Trioxide in Patients with Hepatocellular Carcinoma: A Phase Ii Trial 林家齊; 許駿; 徐志宏; 許瑋玲; 鄭安理; 楊志新; LIN, CHIA-CHI; HSU, CHIUN; HSU, CHIH-HUNG; HSU, WEI-LING; CHENG, ANN-LII; YANG, CHIH-HSIN
國立臺灣大學 2007 A Phase Ii Trial of Weekly Paclitaxel and High-Dose 5-Fluorouracil Plus Leucovorin in Patients with Chemotherapy-Pretreated Metastatic Breast Cancer 林家齊; 鄭安理; 徐志宏; 盧彥伸; 許駿; 葉坤輝; 吳貞瑤; 黃俊升; 楊志新; LIN, CHIA-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; LU, YEN-SHEN; HSU, CHIUN; YEH, KUN-HUEI; WU, CHEN-YAO; HUANG, CHIUN-SHENG; YANG, CHIH-HSIN
臺大學術典藏 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Jeng, Yung-Ming; Chang, Ming-Chu; Wei, Shu-Chen; Wong, Jau-Min; Chang, Yu-Ting; Hsu, Chiun; Chang, Yu-Ting; Hsu, Chiun; Jeng, Yung-Ming; Chang, Ming-Chu; Wei, Shu-Chen; Wong, Jau-Min
國立臺灣大學 2006 PHASE I STUDY OF BIWEEKLY GEMCITABINE FOLLOWED BY OXALIPLATIN AND SIMPLIFIED 48-H INFUSION OF FLUOROURACIL/LEUCOVORIN FOR ADVANCED PANCREATIC CANCER CHANG, HUI-JU; WANG, CHUAN-CHENG; CHENG, ANN-LII; HSU, CHIUN; LU, YEN-SHEN; CHANG, MING-CHU; LIN, JAW-TOWN; WANG, HSIU-PO; LIU, TSANG-WU; CHANG, JANG-YANG; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG; 張慧如; 王全正; 鄭安理; 許駿; 盧彥伸; 章明珠; 林肇堂; 王秀伯; 劉滄梧; 張俊彥; 彭汪嘉康; 陳立宗
國立臺灣大學 2006 Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support 黃書健; 吳恩婷; 柯文哲; 賴凌平; 許駿; 張重義; 邱英世; 王水深; 吳美環; 林芳郁; 陳益祥; HUANG, SHU-CHIEN; WU, EN-TING; KO, WEN-JE; LAI, LING-PING; HSU, CHIUN; CHANG, CHUNG-I; CHIU, ING-SH; WANG, SHOEI-SHEN; WU, MEI-HWAN; LIN, FANG-YUE; CHEN, YIH-SHARNG
國立臺灣大學 2006 Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer 鄭安理; 許駿; 徐志宏; 劉滄梧; 張俊彥; 詹昌明; 趙毅; 尤維蘭; 彭汪嘉康; 陳立宗; CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; LIU, TSANG-WU; CHANG, JANG-YANG; JAN, CHANG-MING; CHAO, YEE; YU, WEI-LAN; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG
國立臺灣大學 2006 Difference in the Incidence Trend of Nasopharyngeal and Oropharyngeal Carcinomas in Taiwan: Implication from Age-Period-Cohort Analysis 許駿; 沈盈君; 洪瑞隆; 張啟仁; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HONG, RUEY-LONG; CHANG, CHEE-JEN; CHENG, ANN-LII
國立臺灣大學 2006 Survival Outcome and Predictors of Gefitinib Antitumor Activity in East Asian Chemonaive Patients with Advanced Nonsmall Cell Lung Cancer 楊志新; 施金元; 陳焜結; 余忠仁; 楊宗穎; 林京珮; 蘇文彬; 高劍虹; 許駿; 張基晟; 楊泮池; YANG, CHIH-HSIN; SHIH, JIN-YUAN; CHEN, KUN-CHIEH; YU, CHONG-JEN; YANG, TSUNG-YING; LIN, CHING-PEI; SU, WEN-PIN; GOW, CHIEN-HUNG; HSU, CHIUN; CHANG, GEE-CHEN; YANG, PAN-CHYR
國立臺灣大學 2005-05 Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler US and Analysis of Circulating Angiogen Hsu, Chiun; Chen, Chiung-Nien; Chen, Li-Tzong; Wu, Chen-Yao; Hsieh, Fon-Jou; Cheng, Ann-Lii
國立臺灣大學 2005 Significant Difference in the Trends of Female Breast Cancer Incidence between Taiwanese and Caucasian Americans: Implications from Age-Period- Cohort Analysis 沈盈君; 張啟仁; 許駿; 鄭安理; SHEN, YING-CHUN; CHANG, CHEE-JEN; HSU, CHIUN; CHENG, ANN-LII
國立臺灣大學 2005 Unexpected Rapid Progression of Metastatic Adenoid Cystic Carcinoma during Treatment with Imatinib Mesylate 顏若芳; 鄭永銘; 曾凱元; 許駿; 洪瑞隆; YEN, RUOH-FANG; JENG, YUNG-MING; TZEN, KAI-YUAN; HSU, CHIUN; HONG, RUEY-LONG
國立臺灣大學 2005 A Phase Ii Study Using Multi-Fractionation of Paclitaxel and Cisplatin by Twice Weekly Schedule, Plus Weekly 24-Hour Infusion of High-Dose 5- Fluorouacil and Leucovorin (Twice Weekly Tp-Hdfl) in the Treatment of Metastatic or Recurrent Esophageal Cancer: T 林家齊; 徐志宏; 葉坤輝; 許駿; 蔡育傑; 鄭安理; LIN, CHIA-CHI; HSU, CHIH-HUNG; YEH, KUN-HUEI; HSU, CHIUN; TSAI, YU-CHIEH; CHENG, ANN-LII
國立臺灣大學 2005 Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler Us and Analysis of Circulating Angiogenic Factors 許駿; 陳炯年; 謝豐舟; 鄭安理; HSU, CHIUN; CHEN, CHIUNG-NIEN; HSIEH, FON-JOU; CHENG, ANN-LII
國立臺灣大學 2005 Survival of Stage Iiib/Iv Non-Small Cell Lung Cancer Patients Who Received Chemotherapy but Did Not Participate in Clinical Trials 郭頌鑫; 楊志新; 余忠仁; 許駿; 鄭安理; 楊泮池; KUO, SUNG-HSIN; YANG, CHIH-HSIN; YU, CHONG-JEN; HSU, CHIUN; CHENG, ANN-LII; YANG, PAN-CHYR
國立臺灣大學 2005 Phase Ii Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5- Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer 葉坤輝; 盧彥伸; 徐志宏; 林靜芳; 許駿; 郭頌鑫; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; LIN, JING-FANG; HSU, CHIUN; KUO, SUNG-HSIN; CHENG, ANN-LII
國立臺灣大學 2005 A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer 盧彥伸; 楊志新; 許駿; LU, YEN-SHEN; YANG, CHIH-HSIN; HSU, CHIUN
國立臺灣大學 2005 Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status 蘇文彬; 楊志新; 余忠仁; 楊泮池; 施金元; 許駿; 楊志新; SU, WEN-PIN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR; SHIH, JIN-YUAN; HSU, CHIUN
國立臺灣大學 2004 肝細胞癌藥物治療之研究 許駿; Hsu, Chiun
國立臺灣大學 2004 Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13 Chie, Wei-Chu; Yang, Chih-Hsin; Hsu, Chiun; Yang, Pan-Chyr
國立臺灣大學 2004 Lack of Efficacy of Troglitazone at Clinically Achievable Concentrations, Alone or in Combination with 9-Cis Retinoic Acid or Cytotoxic Agents, for Hepatocellular Carcinoma Cells. 沈盈君; 許駿; 陳靜怡; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; CHEN, JING-YI; CHENG, ANN-LII
國立臺灣大學 2004 Recent Advances in Non-Surgical Treatment for Advanced Hepatocellular Carcinoma (Hcc) 許駿; 成佳憲; 鄭安理; HSU, CHIUN; CHENG, CHIA-HSIEN; CHENG, ANN-LII
國立臺灣大學 2004 Weekly Gemcitabine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil/ Leucovorin for Locally Advanced or Metastatic Carcinoma of the Biliary Tract. 許駿; 沈盈君; 楊志新; 葉坤輝; 盧彥伸; 徐志宏; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; CHENG, ANN-LII
國立臺灣大學 2004 Phase Ii Study of Combination Doxorubicin, Interferon-Alpha, and High- Dose Tamoxifen Treatment for Advanced Hepatocellular Carcinoma 盧彥伸; 許駿; 李啟誠; 郭頌鑫; 葉坤輝; 楊志新; 徐志宏; 吳貞瑤; 鄭安理; LU, YEN-SHEN; HSU, CHIUN; LI, CHI-CHENG; KUO, SUNG-HSIN; YEH, KUN-HUEI; YANG, CHIH-HSIN; HSU, CHIH-HUNG; WU, CHEN-YAO; CHENG, ANN-LII
國立臺灣大學 2003 Survival-weighted health profile for long-term survivors of acute myelogenous leukemia Hsu, Chiun; Wang, Jung-Der; Hwang, Jing-Shiang; Tien, Hwei-Fang; Chang, Shueh-Mei; Cheng, Ann-Lii; Chen, Yao-Chang; Tang, Jih-Luh; 許駿; 王榮德; 黃景祥; 田蕙芬; 張雪梅; 鄭安理; 陳耀昌; 唐季祿
國立臺灣大學 2003 Rejoinder Hsu, Chiun; Wang, Jung-Der; Yao, Grace; Tang, Jih-Luh
國立臺灣大學 2003 Long-Term Quality of Life (Qol) of Patients with Hematological Malignancies Who Underwent Hematopoietic Stem Cell Transplantation: Comparison between the Utility and the Profile Approaches 許駿; 王榮德; 黃景祥; 姚開屏; 唐季祿; HSU, CHIUN; WANG, JUNG-DER; HWANG, JING-SHIANG; YAO, KAI-PING GRACE; TANG, JIH-LUH
國立臺灣大學 2003 Low-dose thalidomide treatment for advanced hepatocellular carcinoma 許駿; 陳炯年; 陳立宗; 吳貞瑤; 楊培銘; 賴明陽; 李伯皇; 鄭安理; HSU, CHIUN; CHEN, CHIUNG-NIEN; CHEN, LI-TZONG; WU, CHEN-YAO; YANG, PEI-MING; LAI, MING-YANG; LEE, PO-HUANG; CHENG, ANN-LII

Showing items 91-140 of 149  (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page